Vitamin D and inflammatory bowel disease in childre
Not Applicable
- Conditions
- PaediatricsIBDDigestive System
- Registration Number
- PACTR201712002835247
- Lead Sponsor
- tanta university, faculty of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
children with inflammatory bowel disease
Exclusion Criteria
children with recent use of antibiotics (4 weeks), normal vitamin D level, recent change in IBS therapy, history of gut surgery or radiation, chronic drug therapy, children with body mass index (BMI) of more than 25, chronic disease such as renal failure or diabetes mellitus, patients taking vitamin D supplementation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to assess IBD symptoms and severity score after treatment with vitamin D for 6 months.
- Secondary Outcome Measures
Name Time Method correlation between serum vitamin D level and various clinical, radiological and laboratory variables